Japan Pricing Update: Trodelvy, Tepezza Win Usefulness Premiums, Awiqli Struggles

Multiple New Drugs Price-Listed In NHI

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".